Clover (ASX:CLV) Full Year 2024 Results

Key Financial Results

• Revenue: AU$62.2m (down 22% from FY 2023).
• Net income: AU$1.52m (down 76% from FY 2023).
• Profit margin: 2.4% (down from 7.8% in FY 2023). The decrease in margin was driven by lower revenue.
• EPS: AU$0.009 (down from AU$0.037 in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Clover EPS Beats Expectations, Revenues Fall Short

Revenue missed analyst estimates by 3.8%. Earnings per share (EPS) exceeded analyst estimates by 153%.

Looking ahead, revenue is forecast to grow 12% p.a. on average during the next 3 years, compared to a 10% growth forecast for the Chemicals industry in Australia.

Performance of the Australian Chemicals industry.

The company's shares are up 28% from a week ago.

Risk Analysis

Before you take the next step you should know about the 2 warning signs for Clover that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.